Mediators involved in the immunomodulatory effects of apoptotic cells

Transplantation

Volumn 84, Issue 1 SUPPL., 2007, Pages

  Saas, Philippe ^a,c   Bonnefoy, Francis ^a   Kury Paulin, Stephanie ^a   Kleinclauss, François ^a   Perruche, Sylvain ^b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Apoptotic cells; Dendritic cells; Macrophages; Regulatory T cells; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL TRANSPLANTATION; CONFERENCE PAPER; DENDRITIC CELL; ENGRAFTMENT; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MACROPHAGE; MEDIATOR RELEASE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; CELL TRANSPLANTATION; IMMUNE TOLERANCE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 34447557016     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269113.59857.d6     Document Type: Conference Paper

References (28)

1. Chen W, Frank ME, Jin W, Wahl SM. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001; 14: 715.
2. Ariel A, Fredman G, Sun YP, et al. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol 2006; 7: 1209.
3. Fadok VA, Bratton DL, Konowal A, et al. Related Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890.
4. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411.
5. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965.
6. Sen P, Wallet MA, Yi Z, et al. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-{kappa}B activation in dendritic cells. Blood 2007; 109: 653.
7. Kim S, Elkon KB, Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 2004; 21: 643.
8. Stark MA, Huo Y, Burcin TL, et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005; 22: 285.
9. Voll RE, Herrmann M, Roth EA, et al. Immunosuppressive effects of apoptotic cells. Nature 1997; 390: 350.
10. Craciun LI, DiGiambattista M, Schandene L, et al. Anti-inflammatory effects of UV-irradiated lymphocytes: Induction of IL-1Ra upon phagocytosis by monocyte/macrophages. Clin Immunol 2005; 114: 320.
11. Morimoto K, Amano H, Sonoda F, et al. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol 2001; 24: 608.
12. Kleinclauss F, Perruche S, Cahn JY, et al. Administration of donor apoptotic cells: An alternative cell-based therapy to induce tolerance? Transplantation 2003; 75: 43S.
13. Casares N, Pequignot MO, Tesniere A, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005; 202: 1691.
14. Krispin A, Bledi Y, Atallah M, et al. Apoptotic cell thrombospondin-1 and heparin binding domain lead to dendritic cell phagocytic and tolerizing states. Blood 2006; 108: 3580.
15. Skoberne M, Somersan S, Almodovar W, et al. The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function. Blood 2006; 108: 947.
16. Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13: 54.
17. Bittencourt MC, Perruche S, Contassot E, et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001; 98: 224.
18. Kleinclauss F, Perruche S, Masson E, et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2006; 13: 41.
19. Perruche S, Kleinclauss F, de Carvalho Bittencourt M, et al. Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses. Am J Transplant 2004; 4: 1361.
20. Sun E, Gao Y, Chen J, et al. Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ 2004; 11: 1258.
21. Wang Z, Larregina AT, Shufesky WJ, et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 2006; 6: 1297.
22. Delamarre L, Pack M, Chang H, et al. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005; 307: 1630.
23. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875.
24. Maeda A, Schwarz A, Kernebeck K, et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005; 174: 5968.
25. Bushell A, Karim M, Kingsley CI, Wood KJ. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: A potential explanation for the blood-transfusion effect. Transplantation 2003; 76: 449.
26. Snyder EL, Kuter DJ. Apoptosis in transfusion medicine: Of death and dying-is that all there is? Transfusion 2000; 40: 135.
27. Josien R, Douillard P, Guillot C, et al. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest 1998; 102: 1920.
28. Thum T, Bauersachs J, Poole-Wilson PA, et al. The dying stem cell hypothesis: Immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005; 46: 1799.